369 related articles for article (PubMed ID: 6278057)
21. Differential metabolism of (E)-5-(2-iodovinyl)-2'-deoxyuridine (IVDU) by equine herpesvirus type 1- and herpes simplex virus-infected cells.
Kit S; Ichimura H; De Clercq E
Antiviral Res; 1987 Aug; 8(1):41-51. PubMed ID: 2825591
[TBL] [Abstract][Full Text] [Related]
22. Selection of HSV-1 TK gene-transfected murine mammary carcinoma cells resistant to (E)-5-(2-bromovinyl)-2'-deoxyuridine (BVDU) and ganciclovir (GCV).
Degrève B; De Clercq E; Balzarini J
Gene Ther; 2000 Sep; 7(18):1543-52. PubMed ID: 11021592
[TBL] [Abstract][Full Text] [Related]
23. Characterization and susceptibility to antiviral agents of herpes simplex virus type 1 containing a unique thymidine kinase gene with an amber codon between the first and the second initiation codons.
Saijo M; Suzutani T; Mizuta K; Kurane I; Morikawa S
Arch Virol; 2008; 153(2):303-14. PubMed ID: 18066636
[TBL] [Abstract][Full Text] [Related]
24. Induction of thymidine kinase activity by viruses with group B DNA genomes: bovine cytomegalovirus (bovine herpesvirus 4).
Kit S; Kit M; Ichimura H; Crandell R; McConnell S
Virus Res; 1986 Feb; 4(2):197-212. PubMed ID: 3010598
[TBL] [Abstract][Full Text] [Related]
25. Isolation and characterization of acyclovir-resistant mutants of herpes simplex virus.
Field HJ; Darby G; Wildy P
J Gen Virol; 1980 Jul; 49(1):115-24. PubMed ID: 6252285
[TBL] [Abstract][Full Text] [Related]
26. Distinct thymidine kinases encoded by cowpox virus and herpes simplex virus contribute significantly to the differential antiviral activity of nucleoside analogs.
Prichard MN; Williams AD; Keith KA; Harden EA; Kern ER
Antiviral Res; 2006 Aug; 71(1):1-6. PubMed ID: 16530858
[TBL] [Abstract][Full Text] [Related]
27. Production of herpes simplex virus type 1 thymidine kinase in the presence of thymidine analogues.
Zucker ML; Mancini WR; Otto MJ; Lee JJ; Prusoff WH
Antiviral Res; 1986 Mar; 6(2):69-81. PubMed ID: 3010857
[TBL] [Abstract][Full Text] [Related]
28. Suppression of generation and replication of acyclovir-resistant herpes simplex virus by a sensitive virus.
Okuda T; Kurokawa M; Matsuo K; Honda M; Niimura M; Shiraki K
J Med Virol; 2004 Jan; 72(1):112-20. PubMed ID: 14635018
[TBL] [Abstract][Full Text] [Related]
29. Effects of acyclovir, oxetanocin-G, and carbocyclic oxetanocin-G in combinations on the replications of herpes simplex virus type 1 and type 2 in Vero cells.
Saijo M; Suzutani T; Yoshida I
Tohoku J Exp Med; 1992 May; 167(1):57-68. PubMed ID: 1333651
[TBL] [Abstract][Full Text] [Related]
30. Sensitivity of monkey B virus (Cercopithecine herpesvirus 1) to antiviral drugs: role of thymidine kinase in antiviral activities of substrate analogs and acyclonucleosides.
Focher F; Lossani A; Verri A; Spadari S; Maioli A; Gambino JJ; Wright GE; Eberle R; Black DH; Medveczky P; Medveczky M; Shugar D
Antimicrob Agents Chemother; 2007 Jun; 51(6):2028-34. PubMed ID: 17438061
[TBL] [Abstract][Full Text] [Related]
31. Biochemical classification of herpes simplex virus types 1 and 2, and of intermediate strains on the basis of different susceptibilities of thymidine kinase to thymidine analogues.
Just I; Dundaroff S; Falke D
Acta Virol; 1976 Feb; 20(1):31-9. PubMed ID: 7938
[TBL] [Abstract][Full Text] [Related]
32. Characterization of abnormal thymidine kinases induced by drug-resistant strains of herpes simplex virus type 1.
Larder BA; Cheng YC; Darby G
J Gen Virol; 1983 Mar; 64 Pt 3():523-32. PubMed ID: 6298344
[TBL] [Abstract][Full Text] [Related]
33. Effect of acyclovir and presence of cellular and viral thymidine kinase activity in herpes simplex virus infected cells. Brief report.
Harmenberg J; Källander CF; Gronowitz JS
Arch Virol; 1982; 74(2-3):219-25. PubMed ID: 6299236
[TBL] [Abstract][Full Text] [Related]
34. Characterization of pyrimidine deoxyribonucleoside kinase (thymidine kinase) and thymidylate kinase as a multifunctional enzyme in cells transformed by herpes simplex virus type 1 and in cells infected with mutant strains of herpes simplex virus.
Chen MS; Summers WP; Walker J; Summers WC; Prusoff WH
J Virol; 1979 Jun; 30(3):942-5. PubMed ID: 225551
[TBL] [Abstract][Full Text] [Related]
35. Murine mammary FM3A carcinoma cells transformed with the herpes simplex virus type 1 thymidine kinase gene are highly sensitive to the growth-inhibitory properties of (E)-5-(2-bromovinyl)-2'-deoxyuridine and related compounds.
Balzarini J; de Clercq E; Ayusawa D; Seno T
FEBS Lett; 1985 Jun; 185(1):95-100. PubMed ID: 2987041
[TBL] [Abstract][Full Text] [Related]
36. Single nucleotide polymorphisms of thymidine kinase and DNA polymerase genes in clinical herpes simplex virus type 1 isolates associated with different resistance phenotypes.
Schubert A; Gentner E; Bohn K; Schwarz M; Mertens T; Sauerbrei A
Antiviral Res; 2014 Jul; 107():16-22. PubMed ID: 24747042
[TBL] [Abstract][Full Text] [Related]
37. Herpesvirus saimiri pathogenicity enhanced by thymidine kinase of herpes simplex virus.
Hiller C; Tamgüney G; Stolte N; Mätz-Rensing K; Lorenzen D; Hör S; Thurau M; Wittmann S; Slavin S; Fickenscher H
Virology; 2000 Dec; 278(2):445-55. PubMed ID: 11118367
[TBL] [Abstract][Full Text] [Related]
38. Intracellular uptake of thymidine and antiherpetic drugs for thymidine kinase-deficient mutants of herpes simplex virus type 1.
Bae PK; Kim JH; Kim HS; Chung IK; Paik SG; Lee CK
Antiviral Res; 2006 Jul; 70(3):93-104. PubMed ID: 16546268
[TBL] [Abstract][Full Text] [Related]
39. Phosphorylation of arabinofuranosylthymine in non-infected and herpesvirus (TK+ and TK-)-infected cells.
Müller WE; Zahn RK; Arendes F; Falke D
J Gen Virol; 1979 May; 43(2):261-71. PubMed ID: 225422
[TBL] [Abstract][Full Text] [Related]
40. The sensitivity of acyclovir-resistant mutants of herpes simplex virus to other antiviral drugs.
Field H; McMillan A; Darby G
J Infect Dis; 1981 Feb; 143(2):281-5. PubMed ID: 6260876
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]